Evrysdi leads latest CHMP recommendations
The Committee has recommended six medicines for approval at its February 2021 meeting
Read More
Tag: Approvals
Kesimpta and Vazkepa among latest CHMP recommendations
Bumper meeting saw 13 new medicines recommended for approval
Read More
New cancer drugs taking longer to reach NHS patients
A new report by The Institute of Cancer Research (ICR) has found that NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use.
Read More
US beats EU on drug review times, approvals
US regulators have outpaced their European counterparts both on the number of new medicines approved and length of review times between 2011 and 2015, shows a new analysis published by the New England Journal of Medicine.
Read More
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
- ACD440 granted orphan drug status in the EU
